CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 389 enrolled
Drug / intervention
BLI4700 +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03261960
NCT03261960Phase 3Completed
CompareCT.gov

A Safety and Efficacy Comparison of BLI4700 Bowel Preparation Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy

Braintree Laboratories·interventional·Posted Aug 25, 2017·Updated Sep 8, 2021

In Brief

A Phase 3 clinical trial evaluating BLI4700 and Magnesium bowel preparation for Colonoscopy. Completed, enrolled 389 participants across 20 sites.

Detailed Summary

The objective of this study is to compare the safety and efficacy of BLI4700 bowel preparation to an FDA-approved bowel preparation as 2-day, split-dose bowel preparations prior to colonoscopy in adult patients.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsColonoscopy
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
201820192020202120222023202420252026
First PostedAug 25, 2017
Enrollment StartAug 8, 2017
Primary CompletionMar 26, 2018
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 8.9 years ago

Interventions

BLI4700drug

Oral bowel preparation

Magnesium bowel preparationdrug

Oral bowel preparation